HPR209 Pivotal Studies for Rare Diseases: Will They Better Support Market Access?
2024 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2024.10.1633
Eni (Italy)(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
1
Citations
1
h-index
0
i10-index
M Guardigni is an academic researcher from Eni (Italy). The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Pharmaceutical Economics and Policy & Genomics and Rare Diseases. The author has an h-index of 1, co-authored 5 publications.
https://doi.org/10.1016/j.jval.2024.10.1633
https://doi.org/10.1016/j.jval.2024.10.2162
Click to start Chat